Appendix 2A – Application for quotation of securities 2025 Announcements . Financial . News . Regulatory 07.04.2025
Appendix 2A – Application for quotation of securities 2025 Announcements . Financial . News . Regulatory 07.04.2025
Appendix 3C – Final buy-back notification 2025 Announcements . Financial . News . Regulatory 27.03.2025
SCENESSE® Argentinian distribution agreement 2025 Announcements . Clinical . News . Regulatory 17.01.2025
Managing Director’s End of Year Message 2024 2024 Announcements . Corporate . News . Regulatory 23.12.2024
Health Canada validates SCENESSE® New Drug Submission 2024 Announcements . Corporate . News . Regulatory 23.12.2024
Appendix 3H — Notification of cessation of securities 2024 Announcements . Financial . News . Regulatory 04.12.2024
SCENESSE® dosage expansion under review by European Medicines Agency 2024 Announcements . Clinical . News . Regulatory 20.11.2024